Although GMP audit reports are crucial for finished drug authorization files submitted to authorities, manufacturers are confronting rising demands for audits from stakeholders. In this white paper, we will unveil the hidden costs from audit fatigue and presents a systematic approach to alleviate burden for the pharmaceutical industry.